1. Electronic Prescription Service Release 2 Norfolk LPC - March 2016 Dawn Friend / Andrew Hathaway EPS Implementation Team HSCIC 1

2. Deployment Progress - nationally 77% of GP practices 98.6% of pharmacies 90% of DACs Over 17 million patients have a pharmacy nomination Over 212 million release 2 prescriptions sent Over 477 million items dispensed & claimed http://systems.hscic.gov.uk/eps/statshttp://systems.hscic.gov.uk/eps/stats (26 th Feb 2016) 2

3. EPS Utilisation Nationally: Over 1 in 3 prescriptions (38%) are now EPS2 Average utilisation in live practices was 50% (Jan ‘16) (26 th Feb 2016)

4. NHS Midlands & East (East) EPS Live CCGs in Norfolk/Suffolk/Cambs Total no. of pracs Live pracs Planned pracs % Live GP pracs Ave % EPS utilisation (Jan ‘16) Great Yarmouth & Waveney CCG 26 0100%60% Norwich CCG23121152%62% Cambridgeshire & Peterborough CCG 10653950%46% Ipswich & East Suffolk CCG 404010%53% West Suffolk CCG *3 practices went live in Jan 2016 243*013%TBC* South Norfolk CCG24010% Nominations set: 1,216,197 (28%) CCGs in your area with EPS live and planned practices (Feb 2016)

5. EPS Nomination When discussing nomination ensure the patient understands that all future scripts will come to you unless they request otherwise Inappropriate nominations cause confusion and frustration Nominations should be entered into your system promptly Direction of prescriptions is not allowed Inducement is not allowed Nominations do not expire; they can be changed or removed, but only at the request of the patient Nomination is suitable for most patients, especially those on regular repeats and using a regular pharmacy Patient consent doesn’t have to be in writing but you do need to have an auditable process in place

6. EPS Statistics and Data

7. Nomination data – published by HSCIC

9. Controlled Drugs (CDs) The Misuse of Drugs Regs was amended on 1/6/15 and the Medicines Act and NHS legislation changed on 1/7/15, bringing Schedules 2&3 into EPS scope However, technical changes still have to be made to the prescribing and dispensing systems, and be tested and assured.

10. 10 The future of EPS?

11. Phase 4 is the point at which EPS becomes the default option for prescribing, dispensing and processing claims for prescriptions for Primary Care in England. Paper prescriptions will continue to be available for some circumstances but the vast majority of prescriptions will be processed electronically. © HSCIC - 2015 Next Step – ‘Phase 4’

12. How Phase 4 will work There will be 2 main options for patients when Phase 4 becomes live: –Patients continue to have their prescriptions sent to their nominated dispenser (as with EPS2). –Where no nomination is in place (or the patient wishes not to use their nominated dispenser) the patient will be given a token to take to the dispenser they choose to visit. Subject to many pre-requisites (planning, training, consent model, legislation, testing, communications etc.) the initial plan is for Phase 4 to begin in 2016/17 © HSCIC - 2015

13. What to do now Fill out the form to subscribe to the EPS bulletin www.hscic.gov.uk/epssignup www.hscic.gov.uk/epssignup Visit the EPS website for information, advice & guidance ww.hscic.gov.uk/eps ww.hscic.gov.uk/eps Continue talking to patients and setting nominations Make sure your team know how to use EPS in your pharmacy system Smartcards